US Broker Ratings

Oculis Holding AG (OCS) Stock Analysis: Exploring a Potential 100% Upside in Biotech Innovation

Oculis Holding AG (OCS), a Swiss-based biopharmaceutical company, is making waves in the healthcare sector with its promising advancements in ophthalmic drug development. Positioned in the..

AnaptysBio, Inc. (ANAB): Investor Outlook on an 80.50% Potential Upside in the Biotech Sector

AnaptysBio, Inc. (NASDAQ: ANAB), a clinical-stage biotechnology company, has recently captured investor interest with its robust potential upside of 80.50%. Specializing in the development of innovative..

Savara, Inc. (SVRA) Stock Analysis: Exploring a 177% Potential Upside in the Biotech Space

Savara, Inc. (NASDAQ: SVRA), a promising player in the biotechnology sector, is capturing the attention of investors with its focus on addressing rare respiratory diseases. The..

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: A Biotech Gem with a 93.79% Potential Upside

For investors eyeing opportunities in the biotechnology sector, Trevi Therapeutics, Inc. (NASDAQ: TRVI) presents an intriguing proposition. With an impressive potential upside of 93.79%, the company..

HealthStream, Inc. (HSTM) Stock Analysis: Unpacking a 29% Upside Potential

HealthStream, Inc. (HSTM) is a key player in the healthcare information services industry, leveraging its Software-as-a-Service (SaaS) platforms to support a range of healthcare organizations across..

Syndax Pharmaceuticals, Inc. (SNDX) Stock Analysis: A 150% Potential Upside Fuels Investor Interest

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) is capturing the attention of investors in the biotechnology sector, primarily due to its promising growth potential and impressive analyst ratings...

Arcus Biosciences, Inc. (RCUS) Stock Analysis: Exploring an 85% Potential Upside in the Biotechnology Sector

Investors keeping a close watch on the healthcare and biotechnology sectors might find Arcus Biosciences, Inc. (NASDAQ: RCUS) an intriguing opportunity. With its impressive market cap..

Bicara Therapeutics Inc. (BCAX) Growth Potential: Analyst Ratings Signal 72% Upside

Bicara Therapeutics Inc. (BCAX) stands out in the biotechnology sector with a compelling potential upside of 72.07%, as indicated by the consensus of analyst ratings. Based..

Avadel Pharmaceuticals plc (AVDL) Stock Analysis: Exploring a 39% Potential Upside for Investors

Avadel Pharmaceuticals plc (NASDAQ: AVDL), a biopharmaceutical company headquartered in Dublin, Ireland, is capturing the attention of investors with its promising growth prospects in the healthcare..

Nutex Health Inc. (NUTX) Stock Analysis: A Compelling Case for 149.91% Potential Upside

Nutex Health Inc. (NASDAQ: NUTX), a dynamic player in the healthcare sector, is making waves with its robust business model and impressive growth metrics. As a..

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: Exploring the 64% Upside Potential

Praxis Precision Medicines, Inc (NASDAQ: PRAX), a biotechnology company at the forefront of developing therapies for central nervous system disorders, is capturing investor attention with its..

Geron Corporation (GERN) Investor Outlook: Is a 194.72% Potential Upside on the Horizon?

Geron Corporation (NASDAQ: GERN), an innovative player in the biotechnology sector, has captured the attention of investors with its remarkable potential for upside, currently estimated at..

Zymeworks Inc. (ZYME) Stock Analysis: A 27.66% Potential Upside Amid Robust Revenue Growth

Zymeworks Inc. (NASDAQ: ZYME) has emerged as a notable player in the biotechnology sector, specializing in the development of innovative biotherapeutics for cancer and autoimmune diseases...

Niagen Bioscience, Inc. (NAGE) Stock Analysis: Unlocking a Potential 116% Upside in the Biotechnology Sector

Niagen Bioscience, Inc. (NAGE), a promising player in the biotechnology arena, is capturing investor attention with a potential upside of 116.17%. With a market capitalization of..

uniQure N.V. (QURE) Investor Outlook: Biotechnology Innovator with a 25% Upside Potential

uniQure N.V. (NASDAQ: QURE), a biotechnology company based in the Netherlands, is making waves in the healthcare sector, particularly in the realm of gene therapies for..

CareDx, Inc. (CDNA) Stock Analysis: Unlocking a Potential 45.65% Upside with Innovative Transplant Solutions

CareDx, Inc. (NASDAQ: CDNA), a leader in the healthcare diagnostics and research sector, presents an intriguing opportunity for investors seeking exposure to cutting-edge solutions in transplant..

Ardelyx, Inc. (ARDX) Stock Analysis: Unlocking a Potential 125% Upside in the Biotech Sector

Ardelyx, Inc. (NASDAQ: ARDX), a biotechnology company headquartered in Waltham, Massachusetts, is making waves in the healthcare sector with its innovative approach to addressing unmet medical..

CureVac N.V. (CVAC) Stock Analysis: Navigating a Challenging Biotech Landscape with a 40% ROE

CureVac N.V. (NASDAQ: CVAC), a Germany-based biopharmaceutical company, finds itself at a pivotal juncture as it continues to pioneer advancements in messenger ribonucleic acid (mRNA) technology...

Paycom Software, Inc. (PAYC) Stock Analysis: A Look at Its 22.46% Upside Potential

Investors seeking opportunities in the technology sector may want to keep a close eye on Paycom Software, Inc. (NYSE: PAYC), a prominent player in the software..

Q2 Holdings, Inc. (QTWO) Investor Outlook: Exploring a Potential 69% Upside with Robust Analyst Confidence

Q2 Holdings, Inc. (QTWO), a prominent player in the Technology sector, specifically within the Software – Application industry, is drawing significant investor attention. Headquartered in Austin,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds